• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖可能是新冠年轻患者疾病严重程度的一个潜在预测因素:一项回顾性研究。

Obesity as a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study.

机构信息

Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, Wuhan, China.

出版信息

Obesity (Silver Spring). 2020 Oct;28(10):1815-1825. doi: 10.1002/oby.22943. Epub 2020 Sep 2.

DOI:10.1002/oby.22943
PMID:32602202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361308/
Abstract

OBJECTIVE

This study aims to explore the indicators for severity of coronavirus disease 2019 (COVID-19) in young patients between the ages of 18 and 40 years.

METHODS

This retrospective cohort study included 65 consecutively admitted patients with COVID-19 who were between 18 and 40 years old in Zhongnan Hospital of Wuhan University in Wuhan, China. Among them, 53 were moderate cases, and 12 were severe or critical cases. Epidemiological, clinical, and laboratory characteristics and treatment data were collected. A multivariate logistic regression analysis was implemented to explore risk factors.

RESULTS

The patients with severe/critical cases had obviously higher BMI (average 29.23 vs. 22.79 kg/m ) and lower liver computed tomography value (average 50.00 vs. 65.00 mU) than the group of moderate cases. The patients with severe/critical cases had higher fasting glucose, alanine aminotransferase, aspartate aminotransferase, and creatinine compared with patients with moderate cases (all P < 0.01). More severe/critical cases (58.33% vs. 1.92%) had positive urine protein levels. The severe/critical cases also experienced a significant process of serum albumin decline. Logistic regression analysis showed that male sex, high BMI (especially obesity), elevated fasting blood glucose, and urinary protein positivity were all risk factors for young patients with severe COVID-19.

CONCLUSIONS

Obesity is an important predictor of COVID-19 severity in young patients. The main mechanism is related to damage of the liver and kidney.

摘要

目的

本研究旨在探讨 18 至 40 岁年轻 COVID-19 患者严重程度的指标。

方法

本回顾性队列研究纳入了 65 例连续收治于中国武汉武汉大学中南医院的 18 至 40 岁 COVID-19 患者,其中 53 例为中度病例,12 例为重症或危重症病例。收集了流行病学、临床和实验室特征以及治疗数据。采用多变量逻辑回归分析探讨危险因素。

结果

重症/危重症组患者的 BMI(平均 29.23 vs. 22.79 kg/m )明显更高,而肝脏 CT 值(平均 50.00 vs. 65.00 mU)更低。重症/危重症组患者的空腹血糖、丙氨酸转氨酶、天冬氨酸转氨酶和肌酐均高于中度组(均 P<0.01)。更多的重症/危重症患者(58.33% vs. 1.92%)出现尿蛋白阳性。重症/危重症组患者血清白蛋白也明显下降。Logistic 回归分析显示,男性、高 BMI(尤其是肥胖)、空腹血糖升高和尿蛋白阳性都是年轻重症 COVID-19 患者的危险因素。

结论

肥胖是年轻 COVID-19 患者严重程度的一个重要预测因素。其主要机制与肝肾功能损伤有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d59/7361308/9c65ed09a1ad/OBY-28-1815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d59/7361308/97d3a772ff86/OBY-28-1815-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d59/7361308/0daaf8673ccc/OBY-28-1815-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d59/7361308/9c65ed09a1ad/OBY-28-1815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d59/7361308/97d3a772ff86/OBY-28-1815-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d59/7361308/0daaf8673ccc/OBY-28-1815-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d59/7361308/9c65ed09a1ad/OBY-28-1815-g001.jpg

相似文献

1
Obesity as a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study.肥胖可能是新冠年轻患者疾病严重程度的一个潜在预测因素:一项回顾性研究。
Obesity (Silver Spring). 2020 Oct;28(10):1815-1825. doi: 10.1002/oby.22943. Epub 2020 Sep 2.
2
Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.COVID-19 成年患者的肝损伤模式:105 例患者的回顾性分析。
Mil Med Res. 2020 Jun 7;7(1):28. doi: 10.1186/s40779-020-00256-6.
3
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
4
Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.COVID-19 住院非 ICU 患者的临床特征与肝损伤:一项回顾性研究。
Liver Int. 2020 Jun;40(6):1321-1326. doi: 10.1111/liv.14449. Epub 2020 Apr 12.
5
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.中国湖南两中心回顾性队列研究 213 例病例:武汉以外地区 COVID-19 严重程度的临床特征和危险因素。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963035. doi: 10.1177/1753466620963035.
6
Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?患有心血管疾病的基础病会对 COVID-19 住院患者有影响吗?
Heart. 2020 Aug;106(15):1148-1153. doi: 10.1136/heartjnl-2020-316909. Epub 2020 May 25.
7
Liver damage at admission is an independent prognostic factor for COVID-19.入院时的肝损伤是 COVID-19 的一个独立预后因素。
J Dig Dis. 2020 Sep;21(9):512-518. doi: 10.1111/1751-2980.12925.
8
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.中国武汉 COVID-19 患者疾病严重程度、无改善和死亡率的危险因素。
Clin Microbiol Infect. 2020 Jun;26(6):767-772. doi: 10.1016/j.cmi.2020.04.012. Epub 2020 Apr 15.
9
Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019.肥胖与 2019 冠状病毒病患者疾病严重程度的相关性。
Obesity (Silver Spring). 2020 Jul;28(7):1200-1204. doi: 10.1002/oby.22859. Epub 2020 Jun 12.
10
The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China.超重在新型冠状病毒肺炎中的重要性:中国武汉某单中心回顾性分析
Medicine (Baltimore). 2020 Oct 23;99(43):e22766. doi: 10.1097/MD.0000000000022766.

引用本文的文献

1
Impact of Obesity and Ageing on the Expression of Key Mediators of SARS-CoV-2 Infection in Human Adipose Tissue.肥胖和衰老对人脂肪组织中SARS-CoV-2感染关键介质表达的影响。
Int J Mol Sci. 2025 Jul 29;26(15):7313. doi: 10.3390/ijms26157313.
2
Gastrointestinal Manifestations and Outcomes of COVID-19: A Comprehensive Systematic Review and Meta-analysis.新型冠状病毒肺炎的胃肠道表现及结局:一项全面的系统评价和荟萃分析
Cureus. 2023 Oct 14;15(10):e47028. doi: 10.7759/cureus.47028. eCollection 2023 Oct.
3
Prevalence and Determinants of Long COVID Among Patients Attending the Outpatient Department of a Subdistrict Hospital in Haryana.

本文引用的文献

1
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素:前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
2
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.肥胖与 2019 年冠状病毒病严重程度在深圳市某定点医院的相关性研究
Diabetes Care. 2020 Jul;43(7):1392-1398. doi: 10.2337/dc20-0576. Epub 2020 May 14.
3
Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes.
哈里亚纳邦一个社区医院门诊部患者中长新冠的患病率及其决定因素
Cureus. 2023 Sep 26;15(9):e46007. doi: 10.7759/cureus.46007. eCollection 2023 Sep.
4
Metabolic Associated Fatty Liver Disease (MAFLD) and COVID-19 Infection: An Independent Predictor of Poor Disease Outcome?代谢相关脂肪性肝病(MAFLD)与 COVID-19 感染:疾病不良结局的独立预测因子?
Medicina (Kaunas). 2023 Aug 8;59(8):1438. doi: 10.3390/medicina59081438.
5
Analysis of altered level of blood-based biomarkers in prognosis of COVID-19 patients.分析基于血液的生物标志物水平改变对 COVID-19 患者预后的影响。
PLoS One. 2023 Aug 4;18(8):e0287117. doi: 10.1371/journal.pone.0287117. eCollection 2023.
6
Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2-Review of the Evidence.生酮饮食和酮体作为治疗 SARS-CoV-2 的临床支持——证据回顾。
Viruses. 2023 May 27;15(6):1262. doi: 10.3390/v15061262.
7
Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up.新型冠状病毒肺炎(COVID-19)对患者住院后及2个月随访时认知和情绪的影响。
Front Psychol. 2023 May 26;14:1141809. doi: 10.3389/fpsyg.2023.1141809. eCollection 2023.
8
The role of epicardial adipose tissue dysfunction in cardiovascular diseases: an overview of pathophysiology, evaluation, and management.心外膜脂肪组织功能障碍在心血管疾病中的作用:病理生理学、评估和管理概述。
Front Endocrinol (Lausanne). 2023 May 16;14:1167952. doi: 10.3389/fendo.2023.1167952. eCollection 2023.
9
Ghrelin and Leptin Concentrations in Patients after SARS-CoV2 Infection.新型冠状病毒2感染患者体内的胃饥饿素和瘦素浓度
J Clin Med. 2023 May 18;12(10):3551. doi: 10.3390/jcm12103551.
10
Obesity as an independent risk factor for COVID-19 severity and mortality.肥胖是 COVID-19 严重程度和死亡率的独立危险因素。
Cochrane Database Syst Rev. 2023 May 24;5(5):CD015201. doi: 10.1002/14651858.CD015201.
合并糖尿病与未合并糖尿病的 SARS-CoV2 患者的入院高血糖与放射学表现。
Diabetes Res Clin Pract. 2020 Jun;164:108185. doi: 10.1016/j.diabres.2020.108185. Epub 2020 May 1.
4
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体:免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
5
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.中国 26 例 COVID-19 死亡患者的肾脏组织病理分析。
Kidney Int. 2020 Jul;98(1):219-227. doi: 10.1016/j.kint.2020.04.003. Epub 2020 Apr 9.
6
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.致编辑的信:肥胖作为代谢相关脂肪性肝病患者感染 COVID-19 时病情更严重的风险因素。
Metabolism. 2020 Jul;108:154244. doi: 10.1016/j.metabol.2020.154244. Epub 2020 Apr 19.
7
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.入院时 D-二聚体水平预测 COVID-19 患者住院死亡率。
J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859.
8
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.中国武汉 COVID-19 患者疾病严重程度、无改善和死亡率的危险因素。
Clin Microbiol Infect. 2020 Jun;26(6):767-772. doi: 10.1016/j.cmi.2020.04.012. Epub 2020 Apr 15.
9
A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.一种用于早期预测严重 2019 冠状病毒病(COVID-19)的工具:来自中国武汉和广东的多中心研究使用风险列线图。
Clin Infect Dis. 2020 Jul 28;71(15):833-840. doi: 10.1093/cid/ciaa443.
10
Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19.重症新型冠状病毒肺炎中肺血栓形成现象的病理学证据
J Thromb Haemost. 2020 Jun;18(6):1517-1519. doi: 10.1111/jth.14844.